SN-28049

N/A

Report date: 2025/01/26 16:02:37
NME

Base Information

Drug NameSN-28049
Drug Alias NameDNA-intercalating topoisomerase inhibitor (University of Auckland/Auckland UniServices)SN-28049
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Auckland
China Registration ClassN/A

Develop Information

Active CompaniesAuckland Uniservices LtdThe University Of Auckland
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A